Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

AMS:AZRN - Euronext Amsterdam - NL00150006Z9 - Common Stock - Currency: EUR

1.45  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AZRN. AZRN was compared to 24 industry peers in the Interactive Media & Services industry. AZRN may be in some trouble as it scores bad on both profitability and health. AZRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AZRN had negative earnings in the past year.
In the past year AZRN had a positive cash flow from operations.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

AZRN has a worse Return On Assets (-7.46%) than 61.54% of its industry peers.
AZRN has a Return On Equity of -70.23%. This is in the lower half of the industry: AZRN underperforms 76.92% of its industry peers.
Industry RankSector Rank
ROA -7.46%
ROE -70.23%
ROIC N/A
ROA(3y)-9.2%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100

1.3 Margins

AZRN has a Gross Margin of 31.01%. This is in the lower half of the industry: AZRN underperforms 73.08% of its industry peers.
The Profit Margin and Operating Margin are not available for AZRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZRN has been increased compared to 1 year ago.
AZRN has a better debt/assets ratio than last year.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that AZRN is in the distress zone and has some risk of bankruptcy.
AZRN has a Altman-Z score of 0.78. This is in the lower half of the industry: AZRN underperforms 61.54% of its industry peers.
The Debt to FCF ratio of AZRN is 24.87, which is on the high side as it means it would take AZRN, 24.87 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AZRN (24.87) is worse than 65.38% of its industry peers.
AZRN has a Debt/Equity ratio of 3.29. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.29, AZRN is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.29
Debt/FCF 24.87
Altman-Z 0.78
ROIC/WACCN/A
WACC9.99%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.84 indicates that AZRN may have some problems paying its short term obligations.
With a Current ratio value of 0.84, AZRN is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
A Quick Ratio of 0.84 indicates that AZRN may have some problems paying its short term obligations.
AZRN's Quick ratio of 0.84 is on the low side compared to the rest of the industry. AZRN is outperformed by 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M

1

3. Growth

3.1 Past

AZRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -259.28%.
AZRN shows a decrease in Revenue. In the last year, the revenue decreased by -7.11%.
EPS 1Y (TTM)-259.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.78%
Revenue 1Y (TTM)-7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.02%

3.2 Future

The Earnings Per Share is expected to decrease by -10.61% on average over the next years. This is quite bad
AZRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.48% yearly.
EPS Next Y-189.29%
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%
EPS Next 5YN/A
Revenue Next Year3.41%
Revenue Next 2Y6.4%
Revenue Next 3Y7.48%
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1

2

4. Valuation

4.1 Price/Earnings Ratio

AZRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AZRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AZRN is valued a bit cheaper than the industry average as 73.08% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AZRN indicates a somewhat cheap valuation: AZRN is cheaper than 73.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18
EV/EBITDA 8.32
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

AZRN's earnings are expected to decrease with -10.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%

0

5. Dividend

5.1 Amount

No dividends for AZRN!.
Industry RankSector Rank
Dividend Yield N/A

AZERION GROUP N.V.

AMS:AZRN (3/7/2025, 7:00:00 PM)

1.45

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-19 2024-11-19/bmo
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners45.38%
Ins Owner ChangeN/A
Market Cap178.16M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-285.68%
Min EPS beat(2)-426.8%
Max EPS beat(2)-144.56%
EPS beat(4)0
Avg EPS beat(4)-311.68%
Min EPS beat(4)-605.88%
Max EPS beat(4)-69.48%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.49%
Min Revenue beat(2)4.68%
Max Revenue beat(2)10.31%
Revenue beat(4)3
Avg Revenue beat(4)4.57%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)10.31%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-270.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF 18
P/OCF 6.36
P/B 2.61
P/tB N/A
EV/EBITDA 8.32
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.08
FCFY5.56%
OCF(TTM)0.23
OCFY15.72%
SpS4.52
BVpS0.56
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.46%
ROE -70.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.01%
FCFM 1.78%
ROA(3y)-9.2%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 3.29
Debt/FCF 24.87
Debt/EBITDA 5.24
Cap/Depr 39.18%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 0.78
F-Score3
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-259.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.78%
EPS Next Y-189.29%
EPS Next 2Y-47.6%
EPS Next 3Y-10.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.02%
Revenue Next Year3.41%
Revenue Next 2Y6.4%
Revenue Next 3Y7.48%
Revenue Next 5YN/A
EBIT growth 1Y-105.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.78%
EBIT Next 3Y25.55%
EBIT Next 5YN/A
FCF growth 1Y8.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.14%
OCF growth 3YN/A
OCF growth 5YN/A